Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model
Open Access
- 1 March 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 20 (3) , 455-465
Abstract
P110δ phosphoinositide 3‐kinase (PI3K) plays a pivotal role in the recruitment and activation of certain inflammatory cells. Recent findings revealed that the activity of p110δ also contributes to allergenIgE‐induced mast cell activation and vascular permeability. We investigated the role of p110δ in allergic airway inflammation and hyperresponsiveness using IC87114, a selective p110δ inhibitor, in a mouse asthma model. BALB/c mice were sensitized with OVA and, upon OVA aerosol challenge, developed airway eosinophilia, mucus hypersecretion, elevation in cytokine and chemokine levels, up‐regulation of ICAM‐1 and VCAM‐1 expression, and airway hyperresponsiveness. Intratracheal administration of IC87114 significantly ( P P 4 release into the airspace. Histological studies show that IC87114 inhibited OVA‐induced lung tissue eosinophilia, airway mucus production, and inflammation score. In addition, IC87114 significantly ( P FASEB J. 20, 455–465 (2006)Keywords
Funding Information
- Ministry of Health and Welfare (02-PJ1-PG1CH01-0006)
- Korea Science and Engineering Foundation (M02-2004-000-10251-0)
This publication has 53 references indexed in Scilit:
- Selective role of PI3Kδ in neutrophil inflammatory responsesBiochemical and Biophysical Research Communications, 2003
- Regulation of mast-cell and basophil function and survival by IgENature Reviews Immunology, 2002
- A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and ActivationJournal of Experimental Medicine, 2002
- Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant MiceScience, 2002
- Phosphoinositide 3-kinase in immunological systemsSeminars in Immunology, 2002
- AsthmaNew England Journal of Medicine, 2001
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.Journal of Experimental Medicine, 1996
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.Journal of Experimental Medicine, 1992
- Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthmaScience, 1990